|
Volumn 1536, Issue 2-3, 2001, Pages 185-195
|
Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats
|
Author keywords
Fibrogenesis; Hydroxyproline; Insulin like growth factor I; Ito cell; Liver cirrhosis; Malondialdehyde; Oxidative stress; Prolyl hydroxylase
|
Indexed keywords
ANTIFIBROTIC AGENT;
CARBON TETRACHLORIDE;
COLLAGEN TYPE 1;
COLLAGEN TYPE 3;
HYDROXYPROLINE;
MESSENGER RNA;
PHENOBARBITAL;
PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE;
RECOMBINANT SOMATOMEDIN C;
SODIUM CHLORIDE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CELL TRANSFORMATION;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MECHANISM;
ENZYME ACTIVITY;
FIBROGENESIS;
GENE EXPRESSION;
HISTOPATHOLOGY;
IN VIVO STUDY;
ITO CELL;
LIPID PEROXIDATION;
LIVER BIOPSY;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
MALE;
MYOFIBROBLAST;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ACTINS;
ANIMALS;
CARBON TETRACHLORIDE;
COLLAGEN;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FIBROSIS;
HYDROXYPROLINE;
IMMUNOHISTOCHEMISTRY;
INSULIN-LIKE GROWTH FACTOR I;
LIPID PEROXIDATION;
LIVER;
LIVER CIRRHOSIS;
MALE;
MALONDIALDEHYDE;
PROCOLLAGEN-PROLINE DIOXYGENASE;
RATS;
RATS, WISTAR;
RNA, MESSENGER;
ANIMALIA;
RATTUS NORVEGICUS;
|
EID: 0035978532
PISSN: 09254439
EISSN: None
Source Type: Journal
DOI: 10.1016/S0925-4439(01)00045-X Document Type: Article |
Times cited : (53)
|
References (51)
|